{
    "id": "septic_shock_vasopressors_selectAll_v1",
    "type": "selectAll",
    "stem": "The nurse is titrating norepineprhine for a client in septic shock who remains hypotensive after a 30 mL/kg fluid bolus. Which nursing actions are priorities for the safe administration of this medication?",
    "options": [
        {
            "id": "b",
            "text": "Assess the infusion site every 15-30 minutes for signs of extravasation."
        },
        {
            "id": "f",
            "text": "Discontinue the infusion immediately once the target BP is reached."
        },
        {
            "id": "a",
            "text": "Maintain the Mean Arterial Pressure (MAP) at ≥65 mmHg."
        },
        {
            "id": "c",
            "text": "Administer the medication through a large-bore peripheral IV indefinitely."
        },
        {
            "id": "d",
            "text": "Monitor for signs of peripheral ischemia (cold, pale digits)."
        },
        {
            "id": "e",
            "text": "Ensure phentolamine is available on the unit for potential extravasation."
        }
    ],
    "correctOptionIds": [
        "a",
        "b",
        "d",
        "e"
    ],
    "pedagogy": {
        "bloomLevel": "apply",
        "cjmmStep": "takeAction",
        "nclexCategory": "Pharmacological and Parenteral Therapies",
        "difficulty": 4,
        "topicTags": [
            "Sepsis",
            "Critical Care",
            "Pharmacology"
        ]
    },
    "rationale": {
        "correct": "Septic shock management utilizes vasopressors for refractory hypotension. (A) MAP ≥65 is the target for ensuring vital organ perfusion. (B) Norepinephrine is a vesicant; frequent site checks are required. (D) High-dose vasopressors can cause excessive vasoconstriction, leading to peripheral ischemia. (E) Phentolamine is the alpha-adrenergic antagonist antidote used to treat norepinephrine extravasation.",
        "incorrect": "(C) While temporary peripheral use is allowed, vasopressors should be transitioned to a *central line* as soon as possible due to the risk of tissue necrosis. (F) Vasopressors must be *weaned* or tapered slowly rather than stopped abruptly to prevent rebound hypotension.",
        "answerBreakdown": [
            {
                "label": "A",
                "content": "\"Assess the infusion site every 15-30 minutes for signs of extravasation.\" represents a critical metric that must be monitored to evaluate the effectiveness of the current medical plan.",
                "isCorrect": true
            },
            {
                "label": "B",
                "content": "\"Discontinue the infusion immediately once the target BP is reached.\" is a common distractor; it is either a non-specific finding or an action that follows more urgent stabilization.",
                "isCorrect": false
            },
            {
                "label": "C",
                "content": "\"Maintain the Mean Arterial Pressure (MAP) at ≥65 mmHg.\" represents a critical metric that must be monitored to evaluate the effectiveness of the current medical plan.",
                "isCorrect": true
            },
            {
                "label": "D",
                "content": "While plausible in other contexts, \"Administer the medication through a large-bore peripheral IV indefinitely.\" is not the highest priority or most relevant factor in this acute scenario.",
                "isCorrect": false
            },
            {
                "label": "E",
                "content": "Clinically, \"Monitor for signs of peripheral ischemia (cold, pale digits).\" is the most appropriate finding pointing toward the suspected condition and requiring intervention.",
                "isCorrect": true
            },
            {
                "label": "F",
                "content": "Selecting \"Ensure phentolamine is available on the unit for potential extravasation.\" is evidence-based as it directly correlates with the primary clinical cues and pathophysiology.",
                "isCorrect": true
            }
        ],
        "clinicalPearls": [
            "Norepinephrine is the first-line vasopressor for septic shock according to the Surviving Sepsis Campaign."
        ],
        "questionTrap": {
            "trap": "The 'Peripheral IV' Nuance",
            "howToOvercome": "NCSBN questions usually favor central lines for vasopressors. While real-world practice allows short-term peripheral use, the 'Safe/Best' answer in a priority list is to move to a central line."
        },
        "mnemonic": {
            "title": "V-A-S-O",
            "expansion": "Vitals (MAP 65), Assessment of site, Stop (Slowly/Wean), Organs (Ischemia check)."
        },
        "reviewUnits": [
            {
                "heading": "Vasoactive Medications",
                "body": "Norepinephrine increases SVR and MAP. Its main risks are local tissue necrosis and excessive systemic vasoconstriction. Antidote: Phentolamine mesylate.",
                "source": "Critical Care Pharmacology Guidelines 2026"
            }
        ]
    },
    "scoring": {
        "method": "polytomous",
        "maxPoints": 4
    }
}